A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Molecular Triaging of Newly Diagnosed Breast Cancer
- Status
- WITHDRAWN
- Phase
- NA
Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- NA
R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL
- Status
- COMPLETED
- Phase
- PHASE3
Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma.
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
- Status
- TERMINATED
- Phase
- PHASE1
Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Myocet Plus Endoxan for Older Patients With Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2